A61K 2123/00
Preparations for testing in vivo
A61K2123/00 (Preparations for testing in vivo) appears on 1,471 US grants and 640 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,471
- Published applications
- 640
- Assignees
- 664
- Inventors
- 3,057
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 25 | 0 |
| 1978 | 19 | 0 |
| 1979 | 4 | 0 |
| 1980 | 16 | 0 |
| 1981 | 21 | 0 |
| 1982 | 33 | 0 |
| 1983 | 16 | 0 |
| 1984 | 51 | 0 |
| 1985 | 28 | 0 |
| 1986 | 24 | 0 |
| 1987 | 36 | 0 |
| 1988 | 26 | 0 |
| 1989 | 53 | 0 |
| 1990 | 49 | 0 |
| 1991 | 64 | 0 |
| 1992 | 72 | 0 |
| 1993 | 78 | 0 |
| 1994 | 79 | 0 |
| 1995 | 73 | 0 |
| 1996 | 62 | 0 |
| 1997 | 102 | 0 |
| 1998 | 95 | 0 |
| 1999 | 92 | 0 |
| 2000 | 56 | 0 |
| 2001 | 37 | 4 |
| 2002 | 24 | 23 |
| 2003 | 21 | 42 |
| 2004 | 15 | 20 |
| 2005 | 9 | 8 |
| 2006 | 15 | 15 |
| 2007 | 11 | 5 |
| 2008 | 9 | 6 |
| 2009 | 2 | 3 |
| 2010 | 4 | 2 |
| 2011 | 1 | 9 |
| 2012 | 3 | 3 |
| 2013 | 2 | 3 |
| 2014 | 5 | 8 |
| 2015 | 3 | 9 |
| 2016 | 6 | 5 |
| 2017 | 4 | 9 |
| 2018 | 6 | 32 |
| 2019 | 8 | 36 |
| 2020 | 19 | 25 |
| 2021 | 20 | 10 |
| 2022 | 13 | 20 |
| 2023 | 7 | 19 |
| 2024 | 9 | 73 |
| 2025 | 13 | 122 |
| 2026 | 12 | 129 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Gastrin-releasing peptide receptor (GRPR)-targeted compounds and uses thereof8 Sep 2026US 12,728,175 B2Alpha-9 Oncology, Inc.
- Brand-new skeleton 99MTC-FAPI diagnostic probe and use thereof in preparation of drug or reagent for diagnosing tumors14 Jul 2026US 12,678,519 B2Nanjing Nuoyuan Medical Devices Co., Ltd
- Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method therefor30 Jun 2026US 12,667,630 B2Biomolecular Probes Biotechnology (Beijing) Co., Ltd
- Combinations of imaging agent conjugates and application thereof23 Jun 2026US 12,661,416 B2Curadel Surgical Innovations, Inc.
- Cholecystokinin-2 receptor targeted compounds and use thereof2 Jun 2026US 12,642,876 B1Perspective Therapeutics, Inc.
- Process for purifying red blood cell membrane fragments8 Oct 2026US 2026/0306656 A1Ohio State Innovation Foundation
- Development of a platform to noninvasively image car t cells8 Oct 2026US 2026/0306681 A1Dana-Farber Cancer Institute, Inc.
- High-affinity t cell receptor for identifying kras mutation and use thereof1 Oct 2026US 2026/0297159 A1Xlifesc, Ltd.
- Human anti-fgf2 monoclonal antibody (mab), pharmaceutical composition comprising same, use thereof and kit for the detection of cancer in a biological sample comprising said mab1 Oct 2026US 2026/0297170 A1Instituto Butantan
- Oligosaccharide and/or polysaccharide coated iron oxide nanorods and methods of making and use thereof1 Oct 2026US 2026/0298916 A15M Biomed, LLC
Most cited
By later US patents
- Biodegradable injectable nanoparticles724US 5,543,158 AMassachusetts Institute of Technology · 1996
- Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers510US 4,331,647 A1982
- Magnetic iron-dextran microspheres466US 4,452,773 ACanadian Patents and Development Limited · 1984
- Tumoricidal methotrexate-antibody conjugate378US 4,699,784 ACenter for Molecular Medicine and Immunology · 1987
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988